GLP-1 Shortage Impact on Weight Regain
Pharmaceutical availability gaps continue to frustrate patients across all 50 states. This page provides the latest information on availability and alternatives.
Current Availability
Based on the latest data, the shortage situation for semaglutide and tirzepatide products is highly variable by:
- Product and dosage: Initial titration doses are frequently easier to find than target doses
- State and region: Distribution networks favor densely populated areas while rural areas get less
- Pharmacy type: Mail-order options occasionally access products not in chain supply
Individual Dose Status
Starter and Low Doses
Low-dose strengths are typically easier to find because:
- Less demand stays at the lowest dose permanently
- Drug makers focus production on starter doses to maintain onboarding capability
Maintenance and Higher Doses
Target dosing experience worse shortages because:
- Established patients accumulate at maintenance dosing and continue long-term
- Output hasn’t caught up with growing demand
What to Do
First Actions
- Phone before visiting — never drive to the store before verifying stock first
- Try multiple locations — contact multiple stores not just chains
- Get on a notification list — some locations will call when stock arrives
If You Can’t Find It
- Contact your doctor about temporary changes — your prescriber could prescribe an alternative approach
- Ask about 503B pharmacy products — when your medication is formally listed, compounded alternatives can be prescribed
- Try patient support programs — pharma companies offer services to locate medication
Monitoring Resources
Use these resources to stay informed:
- FDA Drug Shortage Database — the most reliable data
- Drug maker supply pages — availability information straight from the companies
- Retail pharmacy apps — can indicate whether it’s in stock
- Support groups — fellow users post current where they found it
We refresh this tracker when new information becomes available.